A carregar...
Publicação
Maternal and perinatal outcomes in pregnant women with rheumatic diseases treated with biosimilar TNF inhibitors
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 513.99 KB | Adobe PDF |
Orientador(es)
Resumo(s)
No safety or efficacy issues arose from using biosimilar TNFi during conception or pregnancy.
Descrição
Palavras-chave
Pregnancy Rheumatic disorders Mothers Perinatal period Tumor necrosis factor inhibitors Biosimilar pharmaceuticals
Contexto Educativo
Citação
Editora
Oxford University Press